Your browser doesn't support javascript.
loading
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ros, J; Matito, J; Villacampa, G; Comas, R; Garcia, A; Martini, G; Baraibar, I; Saoudi, N; Salvà, F; Martin, Á; Antista, M; Toledo, R; Martinelli, E; Pietrantonio, F; Boccaccino, A; Cremolini, C; Dientsmann, R; Tabernero, J; Vivancos, A; Elez, E.
Afiliación
  • Ros J; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Matito J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; The Institute of Cancer Research, London, UK.
  • Comas R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Garcia A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martini G; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
  • Baraibar I; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Saoudi N; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Salvà F; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martin Á; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Antista M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Toledo R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martinelli E; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Boccaccino A; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Cremolini C; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Dientsmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Elez E; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: meelez@vhio.net.
Ann Oncol ; 34(6): 543-552, 2023 06.
Article en En | MEDLINE | ID: mdl-36921693
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: España